Almost 40% of kidney transplant recipients experience an event during the first 3 years. showed significantly lower rates of CVD after kidney transplantation compared with RRT, the incidence still reached up to 30%. Large randomized controlled trials as the Assessment of lescol in Renal Transplantation (ALERT) Study and the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) Study have shown this before. In addition to these traditional risk factors, others such as the duration of renal replacement therapy (RRT), graft function after transplantation, rejection episodes, chronic inflammation and side effects of immunosuppressive medication increase the cardiovascular (CV) risk, especially in this population. Besides CKD, independent risk factors include serum cholesterol, smoking, diabetes, hypertension, male sex and a family history of CVD, and the accumulation of these factors leads to a higher overall risk (OR). The prevalence of cardiovascular disease (CVD) is very high among patients with CKD, especially those on haemodialysis. Cardiovascular events (CVE) remain the leading cause of mortality in patients with chronic kidney disease (CKD).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |